Incyte (INCY) Debt Ratio (2012 - 2026)
Incyte (INCY) posted Debt Ratio of 0.01 for Q1 2026, down 9.25% on a QoQ basis from 0.01 in Q4 2025, and down 26.04% year-over-year from 0.01 in Q1 2025.
Incyte (INCY) Debt Ratio (2012 - 2026) Analysis & Trends
Incyte's Debt Ratio history runs 14 years deep, the most recent figure standing at 0.01 for Q1 2026.
- Quarterly Debt Ratio fell 26.04% year-over-year to 0.01 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.01 (down 26.04% YoY) and the FY2025 annual result came in at 0.01, down 17.95% from the prior year.
- Debt Ratio was 0.01 for Q1 2026 at Incyte, down from 0.01 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.01 in Q3 2024 and bottomed at 0.01 in Q1 2024.
- A 5-year average of 0.01 and a median of 0.01 in 2023 frame the typical range for Debt Ratio.
- Annual changes were most pronounced in 2022 — Debt Ratio slumped 32.23% — and 2024, when it soared 39.63%.
- Incyte's Debt Ratio stood at 0.01 in 2022, then slipped by 9.44% to 0.01 in 2023, then gained by 27.22% to 0.01 in 2024, then fell by 17.95% to 0.01 in 2025, then retreated by 9.25% to 0.01 in 2026.
- Business Quant data shows INCY's Debt Ratio at 0.01 in Q1 2026, 0.01 in Q4 2025, and 0.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Incyte | 23.33 Bn | 19.32 Bn | 1.17 Bn | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |